Midface Volume Deficit Clinical Trial
Official title:
A Prospective, Multi-center, Non-comparative, 52-week Follow-up, Post-market Clinical Investigation of Princess® VOLUME PLUS Lidocaine in Subjects With Midface Volume Deficit
This investigation aims to confirm the safety and effectiveness of Princess VOLUME PLUS Lidocaine in midface volume deficit augmentation and includes a long term safety followup.
This non-interventional study will evaluate subjects treated with Princess VOLUME PLUS Lidocaine for midface volume deficit augmentation. A touch-up treatment will be allowed, on discretion of the treating investigator, if the initial treatment didn't provide optimal correction. The effectiveness parameters will be evaluated based on a validated scale for midface volume deficit scale and confirmed by use of patient reported outcome questionnaires as well as based on photographs to be evaluated by an independent evaluator. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04971876 -
Evaluation of the Safety and Performance of an Injectable Hyaluronic Acid Filler
|
N/A | |
Active, not recruiting |
NCT04132518 -
Sculptra for Correction of Midface Volume Deficit and/or Midface Contour Deficiency
|
N/A | |
Active, not recruiting |
NCT04784299 -
To Evaluate the Performance and Safety of YVOIRE Volume Plus for Improvement of Mid-face Volume
|
N/A | |
Completed |
NCT03289052 -
Restylane Volyme for Correction of Midface Volume Deficit and/or Midface Contour Deficiency
|
N/A | |
Completed |
NCT03097783 -
Restylane Perlane Lidocaine for Correction of Midface Volume Deficit and/or Midface Contour Deficiency
|
N/A |